EUVIMEDEUVIMED entdecken
Crossref

In vivo Anti-Tumour Activity of Novel 2, 3, 7 Trisubstituted Quinazoline Derivatives

Pallavi K J, Jeevani C V, Mayur P, Manjula S N, Satyanarayana S V, Thippeswamy B S, Noolvi M N

American Journal of Pharmacology and Pharmacotherapeutics · 2015

DOI: 10.21767/2393-8862.100034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Pharmacology and Pharmacotherapeutics, 2015. Verfasst von Pallavi K J und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

J, P. K., V, J. C., P, M., N, M. S., V, S. S., S, T. B., & N, N. M. (2015). In vivo Anti-Tumour Activity of Novel 2, 3, 7 Trisubstituted Quinazoline Derivatives. American Journal of Pharmacology and Pharmacotherapeutics. https://doi.org/10.21767/2393-8862.100034

Vancouver

J PK, V JC, P M, N MS, V SS, S TB, et al. In vivo Anti-Tumour Activity of Novel 2, 3, 7 Trisubstituted Quinazoline Derivatives. American Journal of Pharmacology and Pharmacotherapeutics. 2015. doi:10.21767/2393-8862.100034

BibTeX
@article{J2015,
  author = {J, Pallavi K and V, Jeevani C and P, Mayur and N, Manjula S and V, Satyanarayana S and S, Thippeswamy B and N, Noolvi M},
  title = {In vivo Anti-Tumour Activity of Novel 2, 3, 7 Trisubstituted Quinazoline Derivatives},
  journal = {American Journal of Pharmacology and Pharmacotherapeutics},
  year = {2015},
  doi = {10.21767/2393-8862.100034}
}
Kostenlos starten →